Back to Search
ANDREW NAING, M.D.
M.D.
Ophthalmology Physician
NPI: 1609968833Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
213366(NY)
Research & Publications (6)
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.
PMID 19499186·Invest New Drugs·2010
3-trial
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience.
PMID 19165805·Cancer·2009
8-other
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
PMID 17724447·Bone Marrow Transplant·2007
8-other
Developmental therapeutics for myelodysplastic syndromes.
PMID 16403406·J Natl Compr Canc Netw·2006
6-review
Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root.
PMID 15284274·J Clin Oncol·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 202 CANAL ST, STE 401
NEW YORK, NY 10013 - Phone
- (212) 966-7583
Quick Facts
- NPI
- 1609968833
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile